BioWorld

July 23, 2008

View Archived Issues

$125M Deal Sends Mirus Bio Into the Roche RNAi Camp

Roche Holding AG, fresh off its $44 billion offer for Genentech Inc., moved to accelerate its research into RNAi gene silencing technology with the acquisition of Mirus Bio Corp. for $125 million. (BioWorld Today) Read More

BioMarin, Summit Partner for Duchenne Drug in $143M Deal

Read More

Biogen's Strong 2nd Quarter Helped by Tysabri Sales

Read More

Depomed Gets $12M Up Front in Diabetes Deal with Santarus

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Appointments And Advancements

Read More

Financings Roundup

Read More